Pharmaceutical company Galderma has announced that the US Food and Drug Administration (FDA) has approved Restylane Lyft for the augmentation for the chin region. The company shares that the combination
Aesthetic manufacturer Teoxane has introduced Joanna Underhill as new general manager for the UK&I. Teoxane shares that Underhill joins the company from pharmaceutical company Allergan Aesthetics, an AbbVie company, where
Pharmaceutical company Galderma hosted the GAIN Summit London 2025. Held at the Hilton London Bankside, the programme featured sessions and live demonstrations on regenerative medicine, highlighting use of Sculptra and
Pharmaceutical company Galderma welcomed press and specialty guests to an intimate dinner event at Hotel Café Royal, London on October 8. The evening featured presentations from international guest speakers Dr
CCR returned to London for another year of networking and education The UK’s largest medical aesthetics conference, Clinical Cosmetic Regenerative Congress (CCR), welcomed 3,849 attendees to the Excel, London on September 25-26. This year, CCR was a dedicated space to …
“Aesthetics is a fast moving field, and you can never really anticipate what’s around the corner” Dr MJ Rowland-Warmann shares insights into her dental background and recent US innovations Raised in Germany, dentist and aesthetic practitioner Dr MJ Rowland-Warmann was …
Pharmaceutical company Galderma has released data from a clinical trial evaluating the effectiveness of injectable treatments for facial volume loss. Galderma investigated the aesthetic outcomes and appearance of Restylane Lyft
Pharmaceutical company Galderma has unveiled data from a clinical trial evaluating the effectiveness of injectable treatments for facial volume loss. Galderma investigated the aesthetic outcomes and appearance of Restylane Lyft or Volyme in
Three practitioners share their approaches to restoring volume, supporting collagen productionand rebuilding confidence. Over the past two years, aesthetic practitioners have reported a noticeable increase in patients seeking facial rejuvenation following significant weight loss – particularly with concerns around mid-face …
Pharmaceutical company Galderma has announced a net sale of $2.448 billion for the first half of 2025 and 12.2% year-on-year growth. Galderma reported growth in all major categories and a double-digit
